{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:02:44Z","timestamp":1786993364778,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"cooperation and assistance throughout the study","award":["95290"],"award-info":[{"award-number":["95290"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jpsychires.2018.07.008","type":"journal-article","created":{"date-parts":[[2018,7,21]],"date-time":"2018-07-21T22:53:09Z","timestamp":1532213589000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial"],"prefix":"10.1016","volume":"104","author":[{"given":"Vahid","family":"Farnia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haniyeh","family":"Gharehbaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6848-3027","authenticated-orcid":false,"given":"Mostafa","family":"Alikhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Almasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanobar","family":"Golshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faeze","family":"Tatari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omran","family":"Davarinejad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safora","family":"Salemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dena","family":"Sadeghi Bahmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Holsboer-Trachsler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpsychires.2018.07.008_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpsychires.2017.06.004","article-title":"Buprenorphine augmentation improved symptoms of OCD, compared to placebo - results from a randomized, double-blind and placebo-controlled clinical trial","volume":"94","author":"Ahmadpanah","year":"2017","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib2","doi-asserted-by":"crossref","DOI":"10.2174\/0929867325666171222163645","article-title":"A systematic review of evidence-based treatment strategies for obsessive-compulsive disorder resistant to first-line pharmacotherapy","author":"Albert","year":"2017","journal-title":"Curr. Med. Chem."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/pr.117.014399","article-title":"Etiology and pharmacology of neuropathic pain","volume":"70","author":"Alles","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib4","series-title":"Diagnostic and Statistical Manual of Mental Disorders 5th Edition","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib41","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.2044-8317.1988.tb00901.x","article-title":"Synthesizing standardized mean-change measures","volume":"41","author":"Becker","year":"1988","journal-title":"Br. J. Math. Stat. Psychol."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.07.008_bib5","article-title":"Gabapentin therapy in psychiatric disorders: a systematic review","volume":"17","author":"Berlin","year":"2015","journal-title":"Prim. Care Companion CNS Disord."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.07.008_bib42","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib6","series-title":"British National formulary (BNF)","author":"Committee J.F","year":"2004"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Meth."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.07.008_bib8","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1017\/S0033291712001511","article-title":"Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature","volume":"43","author":"Ferrari","year":"2013","journal-title":"Psychol. Med."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-clinpsy-021815-093533","article-title":"The efficacy of exposure therapy for anxiety-related disorders and its underlying mechanisms: the case of OCD and PTSD","volume":"12","author":"Foa","year":"2016","journal-title":"Annu. Rev. Clin. Psychol."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jpsychires.2012.09.015","article-title":"Memantine add-on in moderate to severe obsessive-compulsive disorder: randomized double-blind placebo-controlled study","volume":"47","author":"Ghaleiha","year":"2013","journal-title":"J. Psychiatr. Res."},{"issue":"11","key":"10.1016\/j.jpsychires.2018.07.008_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/archpsyc.1989.01810110048007","article-title":"The Yale-Brown obsessive compulsive scale. I. Development, use, and reliability","volume":"46","author":"Goodman","year":"1989","journal-title":"Arch. Gen. Psychiatr."},{"issue":"5","key":"10.1016\/j.jpsychires.2018.07.008_bib12","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.euroneuro.2015.11.008","article-title":"New treatment models for compulsive disorders","volume":"26","author":"Grant","year":"2016","journal-title":"Eur. Neuropsychopharmacol"},{"issue":"4","key":"10.1016\/j.jpsychires.2018.07.008_bib13","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s00213-013-3067-z","article-title":"In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD)","volume":"228","author":"Haghighi","year":"2013","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.jpsychires.2018.07.008_bib14","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jpsychires.2015.06.020","article-title":"Repetitive Transcranial Magnetic Stimulation (rTMS) improves symptoms and reduces clinical illness in patients suffering from OCD\u2013Results from a single-blind, randomized clinical trial with sham cross-over condition","volume":"68","author":"Haghighi","year":"2015","journal-title":"J. Psychiatr. Res."},{"issue":"13","key":"10.1016\/j.jpsychires.2018.07.008_bib15","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1001\/jama.2017.2200","article-title":"Obsessive-compulsive disorder: advances in diagnosis and treatment","volume":"317","author":"Hirschtritt","year":"2017","journal-title":"Jama"},{"issue":"12","key":"10.1016\/j.jpsychires.2018.07.008_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/ene.13449","article-title":"Gabapentin enacarbil, pregabalin and rotigotine are equally effective in restless legs syndrome: a comparative meta-analysis","volume":"24","author":"Iftikhar","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib17","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.psychres.2017.11.080","article-title":"Patients with OCD report lower quality of life after controlling for expert-rated symptoms of depression and anxiety","volume":"260","author":"Jahangard","year":"2017","journal-title":"Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000446287","article-title":"Repetitive Transcranial Magnetic Stimulation (rTMS) improved symptoms of obsessive compulsive disorders (OCD), but also cognitive performance? \u2013 Results from randomized clinical trial with cross-over design and sham-condition","volume":"73","author":"Jahangard","year":"2016","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.jpsychires.2018.07.008_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.sleep.2017.11.1139","article-title":"Adherence and persistence to ropinirole, pramipexole, and gabapentin in patients with newly diagnosed restless legs syndrome","volume":"44","author":"Kim","year":"2018","journal-title":"Sleep Med."},{"issue":"6","key":"10.1016\/j.jpsychires.2018.07.008_bib20","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5498\/wjp.v2.i6.86","article-title":"Obsessive-compulsive disorder: evidence-based treatments and future directions for research","volume":"2","author":"Lack","year":"2012","journal-title":"World J. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.07.008_bib21","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/2045125312462233","article-title":"Buprenorphine augmentation in the treatment of refractory obsessive-compulsive disorder","volume":"3","author":"Liddell","year":"2013","journal-title":"Therapeut Adv Psychopharmacol."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib22","article-title":"Memantine augmentation improves symptoms in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a randomized controlled trial","author":"Modarresi","year":"2017","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.jpsychires.2018.07.008_bib23","article-title":"Antiepileptic drug monotherapy for epilepsy: a network meta-analysis of individual participant data","volume":"12","author":"Nevitt","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jpsychires.2018.07.008_bib24","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2147\/PRBM.S75106","article-title":"Cognitive-behavioral therapy for obsessive-compulsive disorder: access to treatment, prediction of long-term outcome with neuroimaging","volume":"8","author":"O'Neill","year":"2015","journal-title":"Psychol. Res. Behav. Manag."},{"issue":"1","key":"10.1016\/j.jpsychires.2018.07.008_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.9758\/cpn.2015.13.1.12","article-title":"N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic review","volume":"13","author":"Oliver","year":"2015","journal-title":"Clin psychopharmacol Neurosci.Official Sci J Kor Coll Neuropsychopharmacol"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.07.008_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00406-007-0798-z","article-title":"Does gabapentin lead to early symptom improvement in obsessive-compulsive disorder?","volume":"258","author":"Onder","year":"2008","journal-title":"Eur. Arch. Psychiatr. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.jpsychires.2018.07.008_bib27","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.pnpbp.2005.11.028","article-title":"Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines","volume":"30","author":"Pallanti","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.07.008_bib28","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.pnpbp.2006.04.013","article-title":"Memantine augmentation for refractory obsessive-compulsive disorder","volume":"30","author":"Pasquini","year":"2006","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2018.07.008_bib29","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1176\/ajp.2007.164.6.942","article-title":"The worldwide prevalence of ADHD: a systematic review and metaregression analysis","volume":"164","author":"Polanczyk","year":"2007","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib30","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1093\/ije\/dyt261","article-title":"ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis","volume":"43","author":"Polanczyk","year":"2014","journal-title":"Int. J. Epidemiol."},{"issue":"8","key":"10.1016\/j.jpsychires.2018.07.008_bib31","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/da.22232","article-title":"Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials","volume":"31","author":"Romanelli","year":"2014","journal-title":"Depress. Anxiety"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.07.008_bib32","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/mp.2008.94","article-title":"The epidemiology of obsessive-compulsive disorder in the national comorbidity survey replication","volume":"15","author":"Ruscio","year":"2010","journal-title":"Mol. Psychiatr."},{"issue":"7","key":"10.1016\/j.jpsychires.2018.07.008_bib33","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/14656566.2018.1462795","article-title":"An update and systematic review on drug therapies for the treatment of refractory chronic cough","volume":"19","author":"Ryan","year":"2018","journal-title":"Expet Opin. Pharmacother."},{"issue":"9","key":"10.1016\/j.jpsychires.2018.07.008_bib34","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s40263-015-0272-9","article-title":"N-acetyl cysteine (NAC) in the treatment of obsessive-compulsive disorder: a 16-week, double-blind, randomised, placebo-controlled study","volume":"29","author":"Sarris","year":"2015","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.jpsychires.2018.07.008_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1159\/000457128","article-title":"Repetitive transcranial magnetic stimulation improved symptoms of obsessive-compulsive disorders but not executive functions: results from a randomized clinical trial with crossover design and sham condition","volume":"74","author":"Shayganfard","year":"2016","journal-title":"Neuropsychobiology"},{"issue":"8","key":"10.1016\/j.jpsychires.2018.07.008_bib36","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2215-0366(16)30069-4","article-title":"Pharmacological and psychotherapeutic interventions for management of obsessive-compulsive disorder in adults: a systematic review and network meta-analysis","volume":"3","author":"Skapinakis","year":"2016","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2018.07.008_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/JCP.0b013e3181c856de","article-title":"A single-blinded case-control study of memantine in severe obsessive-compulsive disorder","volume":"30","author":"Stewart","year":"2010","journal-title":"J. Clin. Psychopharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2018.07.008_bib38","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.pbb.2011.10.007","article-title":"The role of glutamate signaling in the pathogenesis and treatment of obsessive-compulsive disorder","volume":"100","author":"Wu","year":"2012","journal-title":"Pharmacol. Biochem. Behav."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618306113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395618306113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,17]],"date-time":"2018-08-17T11:46:05Z","timestamp":1534506365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395618306113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":40,"alternative-id":["S0022395618306113"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.07.008","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of adjunctive gabapentin and memantine in obsessive compulsive disorder: Double-blind, randomized, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2018.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}